Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiko Ebata

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Lab on a Chip|July 9, 2011
Thermal lens detection deviceKazuma Mawatari, Toshinori Ohashi, Tomohiko Ebata, et al.
Biochemical and Biophysical Research Communications|May 18, 2005
Beta2-microglobulin required for cell surface expression of blastocyst MHCToshitaka Tanaka, Tomohiko Ebata, Atsushi Tajima, et al.
Cancer Science|October 27, 2004
Sensitization of human glioblastomas to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by NF-kappaB inhibitorsChinatsu Kasuga, Tomohiko Ebata, Nobuhiko Kayagaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivoAtsushi Tajima, Toshitaka Tanaka, Tomohiko Ebata, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Lab on a Chip|July 9, 2011
Thermal lens detection deviceKazuma Mawatari, Toshinori Ohashi, Tomohiko Ebata, et al.
Biochemical and Biophysical Research Communications|May 18, 2005
Beta2-microglobulin required for cell surface expression of blastocyst MHCToshitaka Tanaka, Tomohiko Ebata, Atsushi Tajima, et al.
Cancer Science|October 27, 2004
Sensitization of human glioblastomas to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by NF-kappaB inhibitorsChinatsu Kasuga, Tomohiko Ebata, Nobuhiko Kayagaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivoAtsushi Tajima, Toshitaka Tanaka, Tomohiko Ebata, et al.
Pageof 1